Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
704.76 Thousand
revenue per share TTM
0.1$
valuation ratios | |
|---|---|
| pe ratio | -0.65 |
| peg ratio | 0.02 |
| price to book ratio | 0.51 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -1.02 |
| price fair value | 0.51 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -64.87% |
| return on equity | -63.52% |
| return on capital employed | -79.93% |
liquidity ratios | |
|---|---|
| current ratio | 7.29 |
| quick ratio | 7.29 |
| cash ratio | 2.39 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 826.43 |
| cash conversion cycle | -826.43 |
| receivables turnover | 0.00 |
| payables turnover | 0.44 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | 0.10 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.09 |
| interest coverage | -52.56 |
| cash flow to debt ratio | -6.81 |
cash flow ratios | |
|---|---|
| free cash flow per share | -8.80 |
| cash per share | 13.79 |
| operating cash flow per share | -8.80 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -6.81 |
| short term coverage ratios | -7.07 |
| capital expenditure coverage ratio | -1,737.95 |
Frequently Asked Questions
When was the last time Kezar Life Sciences, Inc. (NASDAQ:KZR) reported earnings?
Kezar Life Sciences, Inc. (KZR) published its most recent earnings results on 12-11-2025.
What is Kezar Life Sciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kezar Life Sciences, Inc. (NASDAQ:KZR)'s trailing twelve months ROE is -63.52%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kezar Life Sciences, Inc. (KZR) currently has a ROA of -64.87%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KZR's net profit margin stand at?
KZR reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KZR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.29 in the most recent quarter. The quick ratio stood at 7.29, with a Debt/Eq ratio of 0.10.